Carlson Capital L P Tff Pharmaceuticals, Inc. Transaction History

Carlson Capital L P

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.31 - $0.48 $1.11 Million - $1.73 Million	3,595,000 Added 280.86%	4,875,000 $1.71 Million
Q1 2023 May 12, 2023	BUY	$0.62 - $1.1 $23,560 - $41,800	38,000 Added 3.06%	1,280,000 $870,000
Q4 2022 Feb 14, 2023	BUY	$0.84 - $100.75 $812,280 - $97.4 Million	967,000 Added 351.64%	1,242,000 $1.3 Million
Q3 2022 Nov 14, 2022	SELL	$4.61 - $116.0 $115,250 - $2.9 Million	-25,000 Reduced 8.33%	275,000 $1.12 Million
Q2 2022 Aug 15, 2022	SELL	$3.99 - $7.22 $39,900 - $72,200	-10,000 Reduced 3.23%	300,000 $1.7 Million
Q1 2022 May 13, 2022	BUY	$5.28 - $9.17 $485,760 - $843,640	92,000 Added 42.2%	310,000 $1.96 Million
Q4 2021 Feb 11, 2022	SELL	$6.86 - $9.65 $66,548 - $93,614	-9,701 Reduced 4.26%	218,000 $1.93 Million
Q3 2021 Nov 12, 2021	BUY	$7.21 - $10.49 $91,574 - $133,233	12,701 Added 5.91%	227,701 $1.76 Million
Q2 2021 Aug 13, 2021	BUY	$8.48 - $13.61 $381,600 - $612,450	45,000 Added 26.47%	215,000 $2.07 Million
Q1 2021 May 13, 2021	BUY	$12.96 - $19.75 $2.2 Million - $3.36 Million	170,000 New	170,000 $2.31 Million

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $1.53M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Carlson Capital L P, based on Form 13F filings with the SEC.

Stay updated on Carlson Capital L P with notifications on news.